These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 21332118)
1. Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors. D'Angelo ND; Kim TS; Andrews K; Booker SK; Caenepeel S; Chen K; D'Amico D; Freeman D; Jiang J; Liu L; McCarter JD; San Miguel T; Mullady EL; Schrag M; Subramanian R; Tang J; Wahl RC; Wang L; Whittington DA; Wu T; Xi N; Xu Y; Yakowec P; Yang K; Zalameda LP; Zhang N; Hughes P; Norman MH J Med Chem; 2011 Mar; 54(6):1789-811. PubMed ID: 21332118 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. Wurz RP; Liu L; Yang K; Nishimura N; Bo Y; Pettus LH; Caenepeel S; Freeman DJ; McCarter JD; Mullady EL; Miguel TS; Wang L; Zhang N; Andrews KL; Whittington DA; Jiang J; Subramanian R; Hughes PE; Norman MH Bioorg Med Chem Lett; 2012 Sep; 22(17):5714-20. PubMed ID: 22832322 [TBL] [Abstract][Full Text] [Related]
3. Photo-induced decarboxylative C-S bond formation to access sterically hindered unsymmetric S-alkyl thiosulfonates and SS-alkyl thiosulfonates. Guo Y; Lin G; Zhang M; Xu J; Song Q Nat Commun; 2024 Aug; 15(1):7313. PubMed ID: 39181875 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents. Xu X; Zhu Z; Chen S; Fu Y; Zhang J; Guo Y; Xu Z; Xi Y; Wang X; Ye F; Chen H; Yang X Front Chem; 2024; 12():1384301. PubMed ID: 38562527 [No Abstract] [Full Text] [Related]
5. Novel 2-Aminobenzothiazole Derivatives: Docking, Synthesis, and Biological Evaluation as Anticancer Agents. Salih OM; Al-Sha'er MA; Basheer HA ACS Omega; 2024 Mar; 9(12):13928-13950. PubMed ID: 38559989 [TBL] [Abstract][Full Text] [Related]
6. A deep learning-based theoretical protocol to identify potentially isoform-selective PI3Kα inhibitors. Shafiq M; Sherwani ZA; Mushtaq M; Nur-E-Alam M; Ahmad A; Ul-Haq Z Mol Divers; 2024 Feb; ():. PubMed ID: 38305819 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of autophagy inhibition to combat cancer: (vanadium complex)-protein interactions, parameterization, and validation of a new force field. Santos TMR; Tavares CA; Pereira AF; da Cunha EFF; Ramalho TC J Mol Model; 2023 Mar; 29(4):123. PubMed ID: 36995564 [TBL] [Abstract][Full Text] [Related]
9. Insights into the value of statistical models, solvent, and relativistic effects for investigating Re complexes of 2-(4'-aminophenyl)benzothiazole: a potential spectroscopic probe. Andolpho GA; da Cunha EFF; Ramalho TC J Mol Model; 2022 May; 28(6):154. PubMed ID: 35578053 [TBL] [Abstract][Full Text] [Related]
10. QSAR analysis on a large and diverse set of potent phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using MLR and ANN methods. Sadeghi F; Afkhami A; Madrakian T; Ghavami R Sci Rep; 2022 Apr; 12(1):6090. PubMed ID: 35414065 [TBL] [Abstract][Full Text] [Related]
11. Hybrid Materials Based on Magnetic Iron Oxides with Benzothiazole Derivatives: A Plausible Potential Spectroscopy Probe. Corrêa S; Rosa IA; Andolpho GA; Assis LC; Pires MDS; Lacerda LCT; Nogueira FGE; Cunha EFFD; Nepovimova E; Kuca K; Ramalho TC Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921510 [TBL] [Abstract][Full Text] [Related]
13. First Attempts of the Use of Pereira BTL; Gonçalves MA; Mancini DT; Kuca K; Ramalho TC Molecules; 2019 Nov; 24(21):. PubMed ID: 31684009 [TBL] [Abstract][Full Text] [Related]
14. Small molecules that inhibit the late stage of Munc13-4-dependent secretory granule exocytosis in mast cells. Bruinsma S; James DJ; Quintana Serrano M; Esquibel J; Woo SS; Kielar-Grevstad E; Crummy E; Qurashi R; Kowalchyk JA; Martin TFJ J Biol Chem; 2018 May; 293(21):8217-8229. PubMed ID: 29615494 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR. Yu T; Li N; Wu C; Guan A; Li Y; Peng Z; He M; Li J; Gong Z; Huang L; Gao B; Hao D; Sun J; Pan Y; Shen L; Chan C; Lu X; Yuan H; Li Y; Li J; Chen S ACS Med Chem Lett; 2018 Mar; 9(3):256-261. PubMed ID: 29541370 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity. Yang C; Zhang X; Wang Y; Yang Y; Liu X; Deng M; Jia Y; Ling Y; Meng LH; Zhou Y ACS Med Chem Lett; 2017 Aug; 8(8):875-880. PubMed ID: 28835805 [TBL] [Abstract][Full Text] [Related]
17. Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. Liu Y; Wan WZ; Li Y; Zhou GL; Liu XG Oncotarget; 2017 Jan; 8(4):7181-7200. PubMed ID: 27769061 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Crystal Structure, Absolute Configuration and Antitumor Activity of the Enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide. Zhou Z; Li L; Yan N; Du L; Sun C; Sun T Molecules; 2015 Nov; 20(11):20926-38. PubMed ID: 26610458 [TBL] [Abstract][Full Text] [Related]
19. Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. Welker ME; Kulik G Bioorg Med Chem; 2013 Jul; 21(14):4063-91. PubMed ID: 23735831 [TBL] [Abstract][Full Text] [Related]
20. Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity. Wang J; Wang F; Xiao Z; Sheng G; Li Y; Wang Y J Mol Model; 2012 Jul; 18(7):2943-58. PubMed ID: 22139479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]